FATE

#3071
Fate Therapeutics, Inc.
1.48
+2.07%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
1.48
1.48
Jahresspanne
0.66
1.94
Tagesänderung
+2.07%
Monatliche Änderung
+12.12%
6 month change
+28.70%
Jahresänderung
+39.62%
Vorheriger Schlusskurs
1.45
Open
1.48
Bid
Ask
Low
1.48
High
1.48
Volumen
50
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
  • Market Capitalization 175.81 M
  • Employee 181
  • Founded 2007
  • CEO Scott Wolchko
  • Website www.fatetherapeutics.com
  • Headquarter California, United States
  • FIGI BBG000QP35H2
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.85
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Nachrichten